glycine has been researched along with Adenocarcinoma in 33 studies
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Immunodeficient mice were inoculated intrafemorally with the human breast adenocarcinoma cell line MDA-MB-231, then treated 14days later via mini-osmotic pumps inserted intraperitoneally with sulfasalazine, (S)-4-carboxyphenylglycine, or vehicle." | 7.80 | Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain. ( Seidlitz, EP; Singh, G; Ungard, RG, 2014) |
| "Using PCR based restriction fragment length polymorphism and single strand conformational polymorphism, we determined single nucleotide exchanges in the p16 and cyclin D1 genes among 56 esophageal adenocarcinomas (ADC) arising in Barrett's esophagus, 95 cardiac gastric ADC, and in 191 distal gastric ADC." | 7.73 | Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract. ( Gabbert, HE; Geddert, H; Kiel, S; Sarbia, M; Willers, R; Zhang, J; Zotz, RB, 2005) |
| "Forphenicinol, S-2-(3-hydroxy-4-hydroxymethylphenyl)glycine, prolonged the survival period of mice implanted with Meth A fibrosarcoma or Lewis lung carcinoma." | 7.67 | Antitumor effect of forphenicinol, a low molecular weight immunomodifier, in combination with surgery on Meth A fibrosarcoma, Lewis lung carcinoma, and adenocarcinoma 755. ( Ishizuka, M; Naito, K; Okura, A; Sawazaki, Y; Takeuchi, T; Umezawa, H, 1986) |
| " In this study, rigosertib was assessed in combination with gemcitabine in patients with treatment-naïve metastatic pancreatic adenocarcinoma." | 5.20 | A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. ( Aisner, DL; Bajaj, R; Baranda, JC; Bathini, V; Berlin, J; Boles, J; Cho, JK; Cohen, DJ; Cohen, SJ; Coveler, L; Cusnir, M; Fanta, P; Fehrenbacher, L; Gomes, CL; Granfortuna, J; Jimeno, A; Ma, WW; Maguire, R; Maniar, M; McRee, AJ; Menter, AR; Messersmith, WA; Nazemzadeh, R; O'Neil, BH; Olowokure, OO; Phillip, P; Radford, J; Rarick, M; Scott, AJ; Tejani, MA; Wilhelm, F, 2015) |
| " Immunodeficient mice were inoculated intrafemorally with the human breast adenocarcinoma cell line MDA-MB-231, then treated 14days later via mini-osmotic pumps inserted intraperitoneally with sulfasalazine, (S)-4-carboxyphenylglycine, or vehicle." | 3.80 | Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain. ( Seidlitz, EP; Singh, G; Ungard, RG, 2014) |
| "Using PCR based restriction fragment length polymorphism and single strand conformational polymorphism, we determined single nucleotide exchanges in the p16 and cyclin D1 genes among 56 esophageal adenocarcinomas (ADC) arising in Barrett's esophagus, 95 cardiac gastric ADC, and in 191 distal gastric ADC." | 3.73 | Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract. ( Gabbert, HE; Geddert, H; Kiel, S; Sarbia, M; Willers, R; Zhang, J; Zotz, RB, 2005) |
| " To address this problem, we have measured the synthetic rate of fibrinogen (perhaps the major acute phase protein) and plasma amino acid profiles in a group of patients with adenocarcinoma of the pancreas and an ongoing inflammatory response (serum C-reactive protein >10 mg/L in the absence of any other obvious infective or inflammatory cause)." | 3.70 | Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. ( Falconer, JS; Fearon, KC; McMillan, DC; Preston, T; Shenkin, A; Slater, C, 1998) |
| "Forphenicinol, S-2-(3-hydroxy-4-hydroxymethylphenyl)glycine, prolonged the survival period of mice implanted with Meth A fibrosarcoma or Lewis lung carcinoma." | 3.67 | Antitumor effect of forphenicinol, a low molecular weight immunomodifier, in combination with surgery on Meth A fibrosarcoma, Lewis lung carcinoma, and adenocarcinoma 755. ( Ishizuka, M; Naito, K; Okura, A; Sawazaki, Y; Takeuchi, T; Umezawa, H, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (18.18) | 18.7374 |
| 1990's | 11 (33.33) | 18.2507 |
| 2000's | 7 (21.21) | 29.6817 |
| 2010's | 8 (24.24) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Banh, RS | 1 |
| Biancur, DE | 1 |
| Yamamoto, K | 1 |
| Sohn, ASW | 1 |
| Walters, B | 1 |
| Kuljanin, M | 1 |
| Gikandi, A | 1 |
| Wang, H | 1 |
| Mancias, JD | 1 |
| Schneider, RJ | 1 |
| Pacold, ME | 1 |
| Kimmelman, AC | 1 |
| Engür, S | 1 |
| Dikmen, M | 1 |
| Straub, D | 1 |
| Oude Elferink, RPJ | 1 |
| Jansen, PLM | 1 |
| Bergman, JJGHM | 1 |
| Parikh, K | 1 |
| Krishnadath, KK | 1 |
| Ungard, RG | 1 |
| Seidlitz, EP | 1 |
| Singh, G | 1 |
| Yamamoto, H | 1 |
| Higasa, K | 1 |
| Sakaguchi, M | 1 |
| Shien, K | 1 |
| Soh, J | 1 |
| Ichimura, K | 1 |
| Furukawa, M | 1 |
| Hashida, S | 1 |
| Tsukuda, K | 1 |
| Takigawa, N | 1 |
| Matsuo, K | 1 |
| Kiura, K | 1 |
| Miyoshi, S | 1 |
| Matsuda, F | 1 |
| Toyooka, S | 1 |
| O'Neil, BH | 1 |
| Scott, AJ | 1 |
| Ma, WW | 1 |
| Cohen, SJ | 1 |
| Aisner, DL | 1 |
| Menter, AR | 1 |
| Tejani, MA | 1 |
| Cho, JK | 1 |
| Granfortuna, J | 1 |
| Coveler, L | 1 |
| Olowokure, OO | 1 |
| Baranda, JC | 1 |
| Cusnir, M | 1 |
| Phillip, P | 1 |
| Boles, J | 1 |
| Nazemzadeh, R | 1 |
| Rarick, M | 1 |
| Cohen, DJ | 1 |
| Radford, J | 1 |
| Fehrenbacher, L | 1 |
| Bajaj, R | 1 |
| Bathini, V | 1 |
| Fanta, P | 1 |
| Berlin, J | 1 |
| McRee, AJ | 1 |
| Maguire, R | 1 |
| Wilhelm, F | 1 |
| Maniar, M | 1 |
| Jimeno, A | 1 |
| Gomes, CL | 1 |
| Messersmith, WA | 1 |
| Lito, P | 1 |
| Solomon, M | 1 |
| Li, LS | 1 |
| Hansen, R | 1 |
| Rosen, N | 1 |
| Calabrese, C | 1 |
| Pisi, A | 1 |
| Di Febo, G | 1 |
| Liguori, G | 1 |
| Filippini, G | 1 |
| Cervellera, M | 1 |
| Righi, V | 1 |
| Lucchi, P | 1 |
| Mucci, A | 1 |
| Schenetti, L | 1 |
| Tonini, V | 1 |
| Tosi, MR | 1 |
| Tugnoli, V | 1 |
| Degrassi, A | 1 |
| Russo, M | 1 |
| Nanni, C | 1 |
| Patton, V | 1 |
| Alzani, R | 1 |
| Giusti, AM | 1 |
| Fanti, S | 1 |
| Ciomei, M | 1 |
| Pesenti, E | 1 |
| Texido, G | 1 |
| Rachagani, S | 1 |
| Senapati, S | 1 |
| Chakraborty, S | 1 |
| Ponnusamy, MP | 1 |
| Kumar, S | 1 |
| Smith, LM | 1 |
| Jain, M | 1 |
| Batra, SK | 1 |
| GITTERMAN, CO | 1 |
| DULANEY, EL | 1 |
| KACZKA, EA | 1 |
| CAMPBELL, GW | 1 |
| HENDLIN, D | 1 |
| WOODRUFF, HB | 1 |
| Koh, TJ | 1 |
| Field, JK | 1 |
| Varro, A | 1 |
| Liloglou, T | 1 |
| Fielding, P | 1 |
| Cui, G | 1 |
| Houghton, J | 1 |
| Dockray, GJ | 1 |
| Wang, TC | 1 |
| Gross, I | 1 |
| Lhermitte, B | 1 |
| Domon-Dell, C | 1 |
| Duluc, I | 1 |
| Martin, E | 1 |
| Gaiddon, C | 1 |
| Kedinger, M | 1 |
| Freund, JN | 1 |
| Geddert, H | 1 |
| Kiel, S | 1 |
| Zotz, RB | 1 |
| Zhang, J | 1 |
| Willers, R | 1 |
| Gabbert, HE | 1 |
| Sarbia, M | 1 |
| Giger, U | 1 |
| Büchler, M | 1 |
| Farhadi, J | 1 |
| Berger, D | 1 |
| Hüsler, J | 1 |
| Schneider, H | 1 |
| Krähenbühl, S | 1 |
| Krähenbühl, L | 1 |
| Wiesen, KM | 1 |
| Xia, S | 1 |
| Yang, CP | 1 |
| Horwitz, SB | 1 |
| Mori, M | 1 |
| Iwasaki, T | 1 |
| Nakazawa, Y | 1 |
| Namba, Y | 1 |
| Niinaka, M | 1 |
| Yano, Y | 1 |
| Kitada, S | 1 |
| Kimura, H | 1 |
| Naka, N | 1 |
| Okada, T | 1 |
| Nakagawa, M | 1 |
| Maekura, R | 1 |
| Yokota, S | 1 |
| Fossum, B | 1 |
| Gedde-Dahl, T | 1 |
| Breivik, J | 1 |
| Eriksen, JA | 1 |
| Spurkland, A | 1 |
| Thorsby, E | 1 |
| Gaudernack, G | 1 |
| Finkelstein, SD | 1 |
| Przygodzki, R | 1 |
| Pricolo, VE | 1 |
| Sayegh, R | 1 |
| Bakker, A | 1 |
| Swalsky, PA | 1 |
| Keller, G | 1 |
| Gan, LS | 1 |
| Niederer, T | 1 |
| Eads, C | 1 |
| Thakker, D | 1 |
| Capaccioli, S | 1 |
| Di Pasquale, G | 1 |
| Mini, E | 1 |
| Mazzei, T | 1 |
| Quattrone, A | 1 |
| Richards, EW | 1 |
| Long, CL | 1 |
| Nelson, KM | 1 |
| Tohver, OK | 1 |
| Pinkston, JA | 1 |
| Navari, RM | 1 |
| Blakemore, WS | 1 |
| Furuishi, K | 1 |
| Misumi, S | 1 |
| Shoji, S | 1 |
| Inada, M | 1 |
| Yamashita, J | 1 |
| Ogawa, M | 2 |
| Kamohara, H | 1 |
| Sakamoto, K | 1 |
| Mita, S | 1 |
| An, XY | 1 |
| Preston, T | 1 |
| Slater, C | 1 |
| McMillan, DC | 1 |
| Falconer, JS | 1 |
| Shenkin, A | 1 |
| Fearon, KC | 1 |
| Al-Mulla, F | 1 |
| Going, JJ | 1 |
| Sowden, ET | 1 |
| Winter, A | 1 |
| Pickford, IR | 1 |
| Birnie, GD | 1 |
| Lozonschi, L | 1 |
| Sunamura, M | 1 |
| Kobari, M | 1 |
| Egawa, S | 1 |
| Ding, L | 1 |
| Matsuno, S | 1 |
| Watanabe, J | 1 |
| Holinka, CF | 1 |
| Anzai, Y | 1 |
| Kuramoto, H | 1 |
| Gurpide, E | 1 |
| Okura, A | 1 |
| Sawazaki, Y | 1 |
| Naito, K | 1 |
| Ishizuka, M | 1 |
| Takeuchi, T | 1 |
| Umezawa, H | 1 |
| Bibby, MC | 1 |
| Double, JA | 1 |
| Hill, DL | 1 |
| Straight, S | 1 |
| Kasten, FH | 1 |
| Strasser, FF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase III, Multi-center, Randomized, Controlled Study to Compare the Efficacy and Safety of Gemcitabine Alone vs. ON 01910.Na Combined With Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Cancer[NCT01360853] | Phase 3 | 160 participants (Actual) | Interventional | 2011-05-31 | Completed | ||
| Investigating the Use of a Preoperative High-Arginine Nutritional Supplement Prior to Radical Cystectomy[NCT02655081] | Phase 2 | 48 participants (Actual) | Interventional | 2015-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for glycine and Adenocarcinoma
| Article | Year |
|---|---|
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Comb | 2015 |
Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; C-Reactive Protein; Enteral | 2007 |
31 other studies available for glycine and Adenocarcinoma
| Article | Year |
|---|---|
Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer.
Topics: Adenocarcinoma; Aged; Animals; Axons; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Prolifera | 2020 |
The evaluation of the anti-cancer activity of ixazomib on Caco2 colon solid tumor cells, comparison with bortezomib.
Topics: Adenocarcinoma; Antineoplastic Agents; Boron Compounds; Bortezomib; Caco-2 Cells; Caspase 3; Colonic | 2017 |
Glyco-conjugated bile acids drive the initial metaplastic gland formation from multi-layered glands through crypt-fission in a murine model.
Topics: Adenocarcinoma; Animals; Barrett Esophagus; Bile Acids and Salts; Chromatography, High Pressure Liqu | 2019 |
Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Bone and Bones; Breast | 2014 |
Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Asian People; Aspartic Acid; Female; Genetic Predispo | 2014 |
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Alleles; Antineoplastic Agents; Azetidines; Cell Line, Tumor | 2016 |
Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy.
Topics: Adenocarcinoma; Aged; Alanine; Biomarkers, Tumor; Choline; Endoscopy, Gastrointestinal; Female; Gast | 2008 |
Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging.
Topics: Adenocarcinoma; Amino Acid Substitution; Animals; Antineoplastic Agents; Aspartic Acid; Cyclin-Depen | 2010 |
Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin.
Topics: Adenocarcinoma; Amino Acid Substitution; Animals; Aspartic Acid; Cadherins; Down-Regulation; Gene Ex | 2011 |
THE HUMAN TUMOR-EGG HOST SYSTEM. III. TUMOR-INHIBITORY PROPERTIES OF TENUAZONIE ACID.
Topics: Adenocarcinoma; Antineoplastic Agents; Aspergillus; Azaserine; Carcinoma, Bronchogenic; Chick Embryo | 1964 |
Glycine-extended gastrin promotes the growth of lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, | 2004 |
Phosphorylation of the homeotic tumor suppressor Cdx2 mediates its ubiquitin-dependent proteasome degradation.
Topics: Adenocarcinoma; Alanine; Alkaline Phosphatase; Amino Acid Sequence; Amino Acid Substitution; Animals | 2005 |
Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alanine; Barrett Esophagus; Cardia; Case-Control Stu | 2005 |
Wild-type class I beta-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a beta-tubulin mutation.
Topics: Adenocarcinoma; Alkanes; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carbamates; Cell Line, | 2007 |
[A case of lung adenocarcinoma effectively treated with sivelestat and corcicosteroid for drug-induced lung disease due to gefitinib].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Gefitinib; Glycine; Humans; Lung Diseases; Lung Neoplas | 2008 |
p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly-->Asp).
Topics: Adenocarcinoma; Amino Acid Sequence; Aspartic Acid; CD4-Positive T-Lymphocytes; CD8 Antigens; Cells, | 1994 |
K-ras-2 topographic genotyping of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Alanine; Arginine; Aspartic Acid; Codon; Cysteine; DNA, Neoplasm; Exons; Forecasting | 1994 |
Evidence for predominantly paracellular transport of thyrotropin-releasing hormone across CACO-2 cell monolayers.
Topics: 2,4-Dinitrophenol; Adenocarcinoma; Amiloride; Azides; Biological Transport; Cell Line; Cell Membrane | 1993 |
Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Base Sequence; Biological Transport; Cell Line; Colonic Neoplasm | 1993 |
Protein turnover in advanced lung cancer patients.
Topics: Adenocarcinoma; Aged; Blood Urea Nitrogen; Body Mass Index; Body Weight; Calorimetry; Carcinoma, Squ | 1993 |
A novel monoclonal antibody to N-myristoyl glycine moiety found a new N-myristoylated HIV-1 p28gag protein in HIV-1-infected cells.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antibody Specificity; Avian Sarcoma Viruses; Cells, | 1996 |
Neutrophil elastase inhibitor (ONO-5046-Na) inhibits the growth of human lung cancer cell lines transplanted into severe combined immunodeficiency (scid) mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous | 1997 |
Neutrophil elastase inhibitor (ONO-5046.Na) suppresses the proliferation, motility and chemotaxis of a pancreatic carcinoma cell line, Capan-1.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Differentiation; Cell Division; Cell Movement; Chemotaxi | 1997 |
Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response.
Topics: Acute-Phase Reaction; Adenocarcinoma; Adult; Aged; Amino Acids; C-Reactive Protein; Cachexia; Fastin | 1998 |
Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Genes, ras; Genetic H | 1998 |
Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Glycine; Hydroxamic Acids; Lung Neoplasms; Male; Metallo | 1999 |
Effects of serine and glycine on proliferation of an Ishikawa cell variant.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Cell Division; Cell Line; DNA Replication; DNA, Neoplasm; F | 1989 |
Antitumor effect of forphenicinol, a low molecular weight immunomodifier, in combination with surgery on Meth A fibrosarcoma, Lewis lung carcinoma, and adenocarcinoma 755.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Combined Modality Ther | 1986 |
Activity of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-alanine and derivatives against transplantable adenocarcinomata of the mouse colon (MAC).
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Alanine; Animals; Antineoplastic Agents; Colonic Neoplasms; D | 1986 |
Effects of 6-N-allyladenosine on bacterial and mammalian cells.
Topics: Adenocarcinoma; Amides; Azaserine; Carcinoma; Cell Line; Culture Techniques; Escherichia coli; Glyci | 1970 |
Amino acid incorporation patterns during the cell cycle of synchronized human tumor cells.
Topics: Adenocarcinoma; Amino Acids; Arginine; Autoradiography; Cell Division; Cell Nucleus; Culture Techniq | 1966 |